Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

ISTH guidelines for antithrombotic treatment in COVID‐19
Sam Schulman, Michelle Sholzberg, Alex C. Spyropoulos, et al.
Journal of Thrombosis and Haemostasis (2022) Vol. 20, Iss. 10, pp. 2214-2225
Open Access | Times Cited: 145

Showing 26-50 of 145 citing articles:

Step up to the platelet: Role of platelets in inflammation and infection
Agostina Carestia, Laura C. Godin, Craig N. Jenne
Thrombosis Research (2022) Vol. 231, pp. 182-194
Closed Access | Times Cited: 20
Practical Recommendations for Optimal Thromboprophylaxis in Patients with COVID-19: A Consensus Statement Based on Available Clinical Trials
Konstantinos G. Kyriakoulis, Evangelos Dimakakos, Ioannis Kyriakoulis, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 20, pp. 5997-5997
Open Access | Times Cited: 19
Rivaroxaban to prevent major clinical outcomes in non-hospitalised patients with COVID-19: the CARE – COALITION VIII randomised clinical trial
Álvaro Avezum, Haliton Alves de Oliveira, Precil Diego Miranda de Menezes Neves, et al.
EClinicalMedicine (2023) Vol. 60, pp. 102004-102004
Open Access | Times Cited: 11
Prophylactic anticoagulants for non-hospitalised people with COVID-19
Brena Costa Santos, Ronald Luiz Gomes Flumignan, Vinicius Tassoni Civile, et al.
Cochrane library (2023) Vol. 2023, Iss. 8
Open Access | Times Cited: 11
What Role Does Microthrombosis Play in Long COVID?
Toshiaki Iba, Jean M. Connors, Jerrold H. Levy
Seminars in Thrombosis and Hemostasis (2023) Vol. 50, Iss. 04, pp. 527-536
Closed Access | Times Cited: 11
Universal EHRs Clinical Decision Support for Thromboprophylaxis in Medical Inpatients
Alex C. Spyropoulos, Mark Goldin, Ioannis Koulas, et al.
JACC Advances (2023) Vol. 2, Iss. 8, pp. 100597-100597
Open Access | Times Cited: 10
Anticoagulation Strategies in Non–Critically Ill Patients with Covid-19
Zoe McQuilten, Balasubramanian Venkatesh, Vivekanand Jha, et al.
NEJM Evidence (2022) Vol. 2, Iss. 2
Closed Access | Times Cited: 18
A Systematic Review of the Role of Purinergic Signalling Pathway in the Treatment of COVID-19
Vitoria Guero Korb, Iago Carvalho Schultz, Liziane Raquel Beckenkamp, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 7865-7865
Open Access | Times Cited: 8
Efficacy and Safety of Direct Oral Anticoagulants Compared With Heparin for Preventing Thromboembolism in Hospitalized Patients With COVID-19: A Systematic Review and Meta-Analysis
Yong Tian, Tao Pan, Xudong Wen, et al.
Clinical and Applied Thrombosis/Hemostasis (2023) Vol. 29
Open Access | Times Cited: 8
Low-molecular-weight heparin therapy reduces 28-day mortality in patients with sepsis-3 by improving inflammation and coagulopathy
Ze Zhang, Taotao Yan, Danfeng Ren, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 8
COVID-19 and cardiovascular disease in patients with chronic kidney disease
Lucia Del Vecchio, Olga Balafa, Evangelia Dounousi, et al.
Nephrology Dialysis Transplantation (2023) Vol. 39, Iss. 2, pp. 177-189
Open Access | Times Cited: 8
The Community Pharmacy as a Study Center for the Epidemiological Analysis of the Population Vaccination against SARS-CoV-2: Evaluation of Vaccine Safety and Pharmaceutical Service
Jacopo Raffaele Dibenedetto, Michela Cetrone, Marina Antonacci, et al.
Pharmacy (2024) Vol. 12, Iss. 1, pp. 16-16
Open Access | Times Cited: 2
Exploring the therapeutic role of early heparin administration in ARDS management: a MIMIC-IV database analysis
Ling-Xi Xiao, De Liang Zhu, Juan Chen, et al.
Journal of Intensive Care (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 2
Evaluating thromboprophylaxis in the sickle cell disease population: Navigating the evidence gap
Jennifer Davila, Sarah H. O’Brien, William B. Mitchell, et al.
British Journal of Haematology (2024) Vol. 204, Iss. 6, pp. 2184-2193
Closed Access | Times Cited: 2
Advances and current research in primary thromboprophylaxis to prevent hospital‐associated venous thromboembolism
Lara N. Roberts, Roopen Arya, Beverley J. Hunt
British Journal of Haematology (2024) Vol. 204, Iss. 5, pp. 1635-1648
Closed Access | Times Cited: 2
Understanding the mechanisms and treatments of long COVID to address future public health risks
Bohao Li, Junlu Bai, Yan Xiong, et al.
Life Sciences (2024) Vol. 353, pp. 122938-122938
Closed Access | Times Cited: 2
The COVID-19 thrombus: distinguishing pathological, mechanistic, and phenotypic features and management
Richard C. Becker, Udaya S. Tantry, Muhammad H Khan, et al.
Journal of Thrombosis and Thrombolysis (2024)
Open Access | Times Cited: 2
The role of platelets, neutrophils and endothelium in COVID-19 infection
Emanuela Falcinelli, Eleonora Petito, Paolo Gresele
Expert Review of Hematology (2022) Vol. 15, Iss. 8, pp. 727-745
Closed Access | Times Cited: 12
COVID-19 and the Response to Antiplatelet Therapy
Tomáš Bolek, Matej Samoš, Jakub Jurica, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 5, pp. 2038-2038
Open Access | Times Cited: 7
Risk Factors for Postdischarge Major Thromboembolism and Mortality in Hospitalized Patients with COVID-19 with Cardiovascular Comorbidities: Insights from the CORE-19 Registry
Dimitrios Giannis, Mark Goldin, Husneara Rahman, et al.
Thrombosis and Haemostasis (2023) Vol. 123, Iss. 11, pp. 1089-1099
Closed Access | Times Cited: 7
Clinical standards for diagnosis, treatment and prevention of post-COVID-19 lung disease
Dina Visca, Rosella Centis, Emanuele Pontali, et al.
The International Journal of Tuberculosis and Lung Disease (2023) Vol. 27, Iss. 10, pp. 729-741
Open Access | Times Cited: 7
A Review of Hematological Complications and Treatment in COVID-19
Armand N. Yazdani, Arian Abdi, Prathosh Velpuri, et al.
Hematology Reports (2023) Vol. 15, Iss. 4, pp. 562-577
Open Access | Times Cited: 7
Thromboprophylaxis in critical care
Julie Helms, Saskia Middeldorp, Alex C. Spyropoulos
Intensive Care Medicine (2022) Vol. 49, Iss. 1, pp. 75-78
Open Access | Times Cited: 11
Coagulopathy is Initiated with Endothelial Dysfunction and Disrupted Fibrinolysis in Patients with COVID-19 Disease
Fatma Burcu Belen, Gülbahar Darılmaz Yüce, Deniz İlhan Topçu, et al.
Indian Journal of Clinical Biochemistry (2023)
Open Access | Times Cited: 6
Clinical outcomes of children and adolescents with sickle cell disease and COVID-19 infection: A year in review at a metropolitan tertiary pediatric hospital
Olufunke Y. Martin, Deepika S. Darbari, Stefanie Margulies, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 6

Scroll to top